Targeted metabolomics of one-carbon metabolism provides a powerful tool for studying metabolic imbalances that underlie a variety of diseases. By quantifying key metabolites, this service enables the investigation of metabolic dysregulation in conditions like cancer, cardiovascular diseases, and neurodegenerative disorders, helping to identify disease mechanisms and potential therapeutic targets.

One-carbon metabolism metabolites are crucial for cellular processes such as methylation and nucleotide synthesis. Our platform helps researchers identify and validate novel biomarkers associated with disease progression, therapeutic response, and early disease detection. This application is especially valuable in clinical research, where precise biomarker identification can improve diagnosis and treatment strategies.

The regulation of one-carbon metabolism is sensitive to both dietary and environmental factors. Our targeted metabolomics service helps study how nutritional intake (e.g., folate, vitamin B12) and environmental exposures influence metabolic pathways. This application is essential for research into personalized nutrition, dietary recommendations, and the impact of environmental factors on metabolic health.

One-carbon metabolism is intricately linked to epigenetic processes such as DNA methylation, influencing gene expression. Our technology supports research on how one-carbon metabolites affect epigenetic regulation, providing insights into the molecular mechanisms of gene expression and their role in development, aging, and disease.